Devis Pascut

763 total citations
35 papers, 578 citations indexed

About

Devis Pascut is a scholar working on Molecular Biology, Cancer Research and Hepatology. According to data from OpenAlex, Devis Pascut has authored 35 papers receiving a total of 578 indexed citations (citations by other indexed papers that have themselves been cited), including 24 papers in Molecular Biology, 16 papers in Cancer Research and 9 papers in Hepatology. Recurrent topics in Devis Pascut's work include MicroRNA in disease regulation (13 papers), Circular RNAs in diseases (8 papers) and Cancer-related molecular mechanisms research (7 papers). Devis Pascut is often cited by papers focused on MicroRNA in disease regulation (13 papers), Circular RNAs in diseases (8 papers) and Cancer-related molecular mechanisms research (7 papers). Devis Pascut collaborates with scholars based in Italy, Indonesia and Vietnam. Devis Pascut's co-authors include Claudio Tiribelli, Muhammad Yogi Pratama, Lory Saveria Crocè, Caecilia Sukowati, Muhammad Nasrum Massi, Mauro Giuffrè, Giorgio Bedogni, Natalia Rosso, Giuliano Torre and Paola Francalanci and has published in prestigious journals such as Scientific Reports, Journal of Hepatology and BioMed Research International.

In The Last Decade

Devis Pascut

35 papers receiving 573 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Devis Pascut Italy 15 369 259 78 76 70 35 578
Shengli Dong China 14 361 1.0× 227 0.9× 38 0.5× 65 0.9× 130 1.9× 40 580
Tian Lan China 13 435 1.2× 404 1.6× 120 1.5× 101 1.3× 66 0.9× 21 728
Hulin Chang China 14 277 0.8× 177 0.7× 86 1.1× 75 1.0× 83 1.2× 26 525
Wentao Tang China 11 290 0.8× 244 0.9× 36 0.5× 31 0.4× 46 0.7× 23 489
Yaping Tian China 14 538 1.5× 486 1.9× 76 1.0× 58 0.8× 86 1.2× 27 805
Michele Baglioni Italy 12 280 0.8× 189 0.7× 57 0.7× 81 1.1× 160 2.3× 16 512
Tong Huang China 12 236 0.6× 107 0.4× 91 1.2× 84 1.1× 54 0.8× 26 485
Zhongzhou Si China 12 273 0.7× 117 0.5× 59 0.8× 57 0.8× 33 0.5× 38 426
Yu‐De Chu Taiwan 14 239 0.6× 118 0.5× 93 1.2× 61 0.8× 65 0.9× 48 482

Countries citing papers authored by Devis Pascut

Since Specialization
Citations

This map shows the geographic impact of Devis Pascut's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Devis Pascut with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Devis Pascut more than expected).

Fields of papers citing papers by Devis Pascut

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Devis Pascut. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Devis Pascut. The network helps show where Devis Pascut may publish in the future.

Co-authorship network of co-authors of Devis Pascut

This figure shows the co-authorship network connecting the top 25 collaborators of Devis Pascut. A scholar is included among the top collaborators of Devis Pascut based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Devis Pascut. Devis Pascut is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Pascut, Devis, Pablo J. Giraudi, Cristina Banfi, et al.. (2024). Characterization of Circulating Protein Profiles in Individuals with Prader–Willi Syndrome and Individuals with Non-Syndromic Obesity. Journal of Clinical Medicine. 13(19). 5697–5697. 2 indexed citations
2.
Sukowati, Caecilia, Deborah Bonazza, Emiliana Giacomello, et al.. (2024). FRI-516-YI Aurora kinase A and programmed death-ligand 1: expression dynamics in hepatocellular carcinoma development and the regulatory role of the kinase in immune checkpoint modulation. Journal of Hepatology. 80. S429–S430. 1 indexed citations
3.
Giraudi, Pablo J., Devis Pascut, Cristina Banfi, et al.. (2024). Serum proteome signatures associated with liver steatosis in adolescents with obesity. Journal of Endocrinological Investigation. 48(1). 213–225. 4 indexed citations
5.
Tiribelli, Claudio, et al.. (2024). The role of Aurora kinase A in hepatocellular carcinoma: Unveiling the intriguing functions of a key but still underexplored factor in liver cancer. Cell Proliferation. 57(8). e13641–e13641. 12 indexed citations
6.
Pascut, Devis, Mauro Giuffrè, Cristina Bottin, et al.. (2023). Bilirubin-Induced Transcriptomic Imprinting in Neonatal Hyperbilirubinemia. Biology. 12(6). 834–834. 6 indexed citations
7.
Pascut, Devis, Emiliano Dalla, Giulia Antoniali, et al.. (2023). Clinical Significance of Apurinic/Apyrimidinic Endodeoxyribonuclease 1 and MicroRNA Axis in Hepatocellular Carcinoma. Journal of Clinical and Translational Hepatology. 0(0). 0–0. 9 indexed citations
9.
Pascut, Devis, et al.. (2023). Liquid biopsy: New opportunities for precision medicine in hepatocellular carcinoma care. Annals of Hepatology. 29(2). 101176–101176. 6 indexed citations
10.
Cavallaro, Marco, Claudio Tiribelli, Devis Pascut, et al.. (2022). MicroRNAs Related to TACE Treatment Response: A Review of the Literature from a Radiological Point of View. Diagnostics. 12(2). 374–374. 10 indexed citations
11.
Silvestre, Alessia Di, Elisa Mitri, Devis Pascut, et al.. (2020). Repeated double cross-validation applied to the PCA-LDA classification of SERS spectra: a case study with serum samples from hepatocellular carcinoma patients. Analytical and Bioanalytical Chemistry. 413(5). 1303–1312. 43 indexed citations
12.
Pratama, Muhammad Yogi, Luisa Cavalletto, Claudio Tiribelli, Liliana Chemello, & Devis Pascut. (2020). Selection and validation of miR-1280 as a suitable endogenous normalizer for qRT-PCR Analysis of serum microRNA expression in Hepatocellular Carcinoma. Scientific Reports. 10(1). 3128–3128. 10 indexed citations
13.
Pratama, Muhammad Yogi, et al.. (2020). Circulatory miRNA as a Biomarker for Therapy Response and Disease-Free Survival in Hepatocellular Carcinoma. Cancers. 12(10). 2810–2810. 24 indexed citations
14.
Pascut, Devis, et al.. (2020). Weighted miRNA co-expression networks analysis identifies circulating miRNA predicting overall survival in hepatocellular carcinoma patients. Scientific Reports. 10(1). 18967–18967. 21 indexed citations
15.
Pascut, Devis, Luisa Cavalletto, Muhammad Yogi Pratama, et al.. (2019). Serum miRNA Are Promising Biomarkers for the Detection of Early Hepatocellular Carcinoma after Treatment with Direct-Acting Antivirals. Cancers. 11(11). 1773–1773. 28 indexed citations
16.
Pratama, Muhammad Yogi, Devis Pascut, Muhammad Nasrum Massi, & Claudio Tiribelli. (2019). The role of microRNA in the resistance to treatment of hepatocellular carcinoma. Annals of Translational Medicine. 7(20). 577–577. 40 indexed citations
17.
Pascut, Devis, et al.. (2019). A comparative characterization of the circulating miRNome in whole blood and serum of HCC patients. Scientific Reports. 9(1). 8265–8265. 34 indexed citations
18.
Pratama, Muhammad Yogi, et al.. (2019). Circulating miR-3185 as a predictive marker for overall survival in patients with hepatocellular carcinoma. Digestive and Liver Disease. 51. e36–e36. 1 indexed citations
19.
Pascut, Devis, Danilo Licastro, Simeone Dal Monego, et al.. (2016). Circulating microRNA in hepatocellular carcinoma as prognostic biomarkers. Digestive and Liver Disease. 48. e23–e23. 1 indexed citations
20.
Popovič, P., Claudio Tiribelli, & Devis Pascut. (2016). The role of mir-124 and aurora kinase A in the multidrug resistance in HCC. Digestive and Liver Disease. 48. e8–e8. 1 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026